Pharmaceutical Business review

Amicas completes acquisition of Emageon

Amicas’s acquisition of Emageon is expected to create a leading healthcare IT vendor, with more than 1,000 customers, that offers one of the most comprehensive image and information management solutions on the market.

The combined solution suite will include radiology picture archiving and communication systems (PACS), cardiology PACS, radiology information systems, cardiology information systems, revenue cycle management systems, referring physician tools, business intelligence tools, and electronic medical record-enabling enterprise content management capabilities.

Amicas now owns 100% of Emageon. The company had previously purchased 88% of the Emageon common stock outstanding pursuant to the tender offer which expired on April 1, 2009. Pursuant to the merger, Emageon shareholders who did not tender their shares, will receive the same $1.82 per share in cash, without interest and less any required withholding taxes, that was paid to shareholders in the tender offer.

With the completion of the merger, Emageon has become a wholly-owned subsidiary of Amicas, and Emageon shares will cease to be traded on the Nasdaq global market.

Stephen Kahane, CEO and chairman of Amicas, said: “Amicas and Emageon have a shared vision that is focused on providing outstanding image and information management solutions in healthcare. We at Amicas are extremely excited about joining forces with Emageon, and we believe that our combined offerings are in line with the future of imaging and will result in great innovation for our combined customer base and the future of the market.”